AIROS Medical received 510(k) clearance to market its updated AIROS 8 sequential compression therapy device and garment system for treatment of breast cancer patients with lymphedema.
The AIROS 8 uses pneumatic air compression to inflate accessory garments. The inflation and deflation sequences move the lymphatic fluid in the correct physiological direction.
The company has marketed the AIROS 8 and its garments since August 2018, but the new clearance allows the company to treat breast-cancer patients with lymphedema more effectively.
The AIROS 8 is also available for use with leg garments and arm garments, primarily for patients with venous complications.